Confidential Disclosure Agreement In Clinical Research Template for Denmark

1. Third Party Disclosure: Required when confidential information may need to be shared with approved third parties such as contract research organizations or regulatory authorities

2. Publication Rights: Include when parties need to address rights to publish research results while protecting confidential information

3. Intellectual Property Rights: Include when confidential information may involve patentable inventions or other IP rights

4. Clinical Trial Regulations Compliance: Include when the CDA specifically relates to a clinical trial subject to EU Clinical Trials Regulation

5. Breach Notification: Detailed procedures for handling and reporting confidentiality breaches, particularly relevant for high-sensitivity data

6. Insurance and Liability: Include when parties want to specify liability limitations and insurance requirements

7. Language: Include when agreement needs to be in both English and Danish with specification of prevailing version

1. Schedule 1 - Description of Clinical Research Project: Detailed description of the research project and context for information sharing

2. Schedule 2 - Categories of Confidential Information: Detailed listing of types of confidential information to be shared

3. Schedule 3 - Authorized Recipients: List of individuals or roles authorized to receive confidential information

4. Schedule 4 - Security Protocols: Specific technical and organizational security measures required

5. Schedule 5 - Data Processing Terms: Detailed GDPR-compliant data processing terms if personal data is involved